Patients without improvement after taking selected top selling drugs 2015

This statistic describes the number of patients with no improvement after taking selected top selling drugs worldwide, as of 2015, per every patient with improvement. For example, for every person heartburn medicine Nexium does help, at the same time it fails to improve the condition for 24 other people taking this drug. The inefficiency of many drugs is one major argument for developing personalized or precision medicines.

Number of patients with no improvement after taking selected top selling drugs worldwide as of 2015 (per every patient with improvement)*

Brand name (condition)Number of patients without improvement per every patient with improvement
Remicade (Crohn's disease)3
Humira (arthritis)3
Enbrel (psoriasis)3
Abilify (schizophrenia)4
Cymbalta (depression)8
Neulasta (neutropenia)12
Copaxone (multiple sclerosis)15
Advair Diskus (asthma)19
Crestor (high cholesterol)19
Nexium (heartburn)24
Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

April 2015

Region

Worldwide

Survey time period

as of 2015

Supplementary notes

* Based on published number needed to treat (NNT) figures.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Personalized medicine"

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.